What is ACXEL?
Founded in 2016 and headquartered in Foshan, China, ACXEL operates as a provider of digital microfluidic technology platforms. This advanced technology is crucial for applications requiring precise fluid handling at a micro-scale, often utilized in life sciences, diagnostics, and advanced manufacturing. The company's focus on this niche technology positions it within the rapidly evolving landscape of biotech and advanced materials.
How much funding has ACXEL raised?
ACXEL has raised a total of $10M across 1 funding round:
Other Financing Round
$10M
Other Financing Round (2022): $10M with participation from Cowincapital, Qiming Venture Partners, Linear Capital, G&L Ventures, and Country Garden Venture Capital
Key Investors in ACXEL
Cowincapital
Cowin Capital is a venture capital firm with a strong track record since 2000, specializing in investments across various enterprises and facilitating their entry into China's capital market, with a notable success rate in IPOs.
Qiming Venture Partners
Qiming Venture Partners is a leading venture capital firm focused on investing in innovative companies in technology, healthcare, and AI, providing strategic guidance and resources to support startup growth.
Linear Capital
Linear Capital is a Canadian business development firm that offers guidance and advisory services to emerging companies within the financial marketplace, aiming to accelerate growth and shareholder value.
What's next for ACXEL?
The substantial enterprise-level funding and recent strategic investment indicate ACXEL is poised for significant scaling and market expansion. This capital infusion will likely fuel further research and development, enhance production capabilities, and strengthen its global market presence. The company's trajectory suggests a move towards broader commercialization and potentially establishing new industry benchmarks in digital microfluidics.
See full ACXEL company page
